Sanofi India posts 53.6% profit to ₹117cr, pays ₹75/share dividend
Sanofi India just reported a strong 53.6% jump in profits for Q3 2026, hitting ₹117 crore compared to last year's ₹76 crore.
They're also rewarding shareholders with a ₹75-per-share interim dividend.
Revenue saw a modest boost to ₹491.7 crore, and the company's shares climbed 7.02% on Thursday, closing at ₹3,202.
Sanofi India sees double-digit diabetes growth
A huge 85% surge in public sector business and steady gains in diabetes treatments like Lantus and Soliqua helped fuel this growth.
Domestic sales were up slightly, exports saw double-digit gains, and partnerships in heart health and other areas stayed solid.
MD Deepak Arora shared that there's "Our diabetes business is firmly in momentum, growing in double digits quarter-on-quarter (at a YTD-level)." as Sanofi widens access to innovative therapies across the country.
The dividend will be given out based on records as of November 5, 2026.